Tamás Jordán

Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers

L. Molnár, T. Solymosi, J. McDermott, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Investigations of the mechanism behind the rapid absorption of nano‐amorphous abiraterone acetate

T. Solymosi, H. Glavinas, G. Heltovics, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.

L. Molnár, T. Solymosi, G. Filipcsei, 2017, International journal of pharmaceutics.

Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect

L. Molnár, T. Solymosi, G. Filipcsei, 2017, Cancer Chemotherapy and Pharmacology.

Dose Finding and Food Effect Studies of a Novel Abiraterone Acetate Formulation for Oral Suspension in Comparison to a Reference Formulation in Healthy Male Subjects

L. Molnár, T. Solymosi, G. Filipcsei, 2021, Pharmaceutics.

Solubility Measurements at 296 and 310 K and Physicochemical Characterization of Abiraterone and Abiraterone Acetate

T. Solymosi, F. Tóth, H. Glavinas, 2018, Journal of Chemical & Engineering Data.

Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation

L. Molnár, T. Solymosi, J. McDermott, 2019, AAPS PharmSciTech.

Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation

L. Molnár, T. Solymosi, J. McDermott, 2019, AAPS PharmSciTech.

Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation

L. Molnár, T. Solymosi, J. McDermott, 2019, AAPS PharmSciTech.